Zacks Investment Research downgraded shares of ORTHOFIX INTL (OFIX) from NEUTRAL to UNDERPERFORM on May 13, 2013, with a target price of $25.10.
Orthofix International N.V. is a leading provider of high-value, minimally invasive medical devices for the orthopaedic and trauma markets. Orthofix is well positioned to expand its focus and capitalise on the growing medical acceptance of high technology in orthopaedic treatment and spine repair. The company sells its diverse product line in different countries through its subsidiaries and distribution agreements with leading orthopaedic companies, including Sulzer Medica Group, Sofamor Danek Group, Kendall Healthcare Products and B. Braun. (PRESS RELEASE)
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on ORTHOFIX INTL (OFIX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment